Literature DB >> 10823626

Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors.

H W Husstedt1, M Sickert, H Köstler, B Haubitz, H Becker.   

Abstract

The aim of this study was to quantify imaging characteristics of fast fluid-attenuated inversion recovery (FLAIR) sequence in brain tumors compared with T1-postcontrast- and T2-sequences. Fast-FLAIR-, T2 fast spin echo (FSE)-, and T1 SE postcontrast images of 74 patients with intracranial neoplasms were analyzed. Four neuroradiologists rated signal intensity and inhomogeneity of the tumor, rendering of cystic parts, demarcation of the tumor vs brain, of the tumor vs edema and of brain vs edema, as well as the presence of motion and of other artifacts. Data analysis was performed for histologically proven astrocytomas, glioblastomas, and meningiomas, for tumors with poor contrast enhancement, and for all patients pooled. Only for tumors with poor contrast enhancement (n = 12) did fast FLAIR provide additional information about the lesion. In these cases, signal intensity, demarcation of the tumor vs brain, and differentiation of the tumor vs edema were best using fast FLAIR. In all cases, rendering of the tumor's inner structure was poor. For all other tumor types, fast FLAIR did not give clinically relevant information, the only exception being a better demarcation of the edema from brain tissue. Artifacts rarely interfered with evaluation of fast-FLAIR images. Thus, fast FLAIR cannot replace T2-weighted series. It provides additional information only in tumors with poor contrast enhancement. It is helpful for defining the exact extent of the edema of any tumor but gives little information about their inner structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823626     DOI: 10.1007/s003300050997

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  Post-contrast FLAIR MR imaging of the brain in children: normal and abnormal intracranial enhancement.

Authors:  Hyun Woo Goo; Choong-Gon Choi
Journal:  Pediatr Radiol       Date:  2003-10-10

2.  Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Taryar Zaw; Albert Lai; Phioanh L Nghiemphu; Robert Harris; Shadi Lalezari; Naveed Wagle; Kourosh M Naeini; Jose Carrillo; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-01-22       Impact factor: 12.300

3.  Metabolic deactivation of low-grade glioma during chemotherapy.

Authors:  Ulrich Roelcke; Matthias Wyss; Esther Bärtschi; Silvia Hofer
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

4.  Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study.

Authors:  P Tiwari; P Prasanna; L Wolansky; M Pinho; M Cohen; A P Nayate; A Gupta; G Singh; K J Hatanpaa; A Sloan; L Rogers; A Madabhushi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-15       Impact factor: 3.825

Review 5.  In vivo imaging of neuroinflammation in schizophrenia.

Authors:  Ofer Pasternak; Marek Kubicki; Martha E Shenton
Journal:  Schizophr Res       Date:  2015-06-03       Impact factor: 4.939

6.  Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Shadi Lalezari; Taryar Zaw; Kourosh Motevalibashinaeini; Paul S Mischel; Whitney B Pope
Journal:  J Neurooncol       Date:  2011-06-25       Impact factor: 4.130

7.  Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-12-28       Impact factor: 12.300

8.  Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases.

Authors:  Nil Ercan; Serap Gultekin; Halil Celik; Turgut E Tali; Yusuf A Oner; Gonca Erbas
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

9.  Early metabolic responses in temozolomide treated low-grade glioma patients.

Authors:  Matthias Wyss; Silvia Hofer; Matthias Bruehlmeier; Martin Hefti; Catrina Uhlmann; Esther Bärtschi; Ulrich Wolf Buettner; Ulrich Roelcke
Journal:  J Neurooncol       Date:  2009-04-18       Impact factor: 4.130

10.  Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.

Authors:  Robert J Harris; Timothy F Cloughesy; Whitney B Pope; Sergio Godinez; Yutaka Natsuaki; Phioanh L Nghiemphu; Heiko Meyer; Dominik Paul; Yalda Behbahanian; Albert Lai; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2013-01-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.